Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

Steven M. Harris, Esq.  |  Issue: April 2020  |  March 17, 2020

Real time: This category covers synchronous audio or video interaction—what most people actually consider to be telemedicine. All states cover this form of telemedicine, but some states, including Alaska, Maine, New Jersey and Oregon, reimburse for audio-only technology.

Legal & Regulatory Framework

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Telemedicine is governed primarily by state laws and regulations, with layers of federal law regarding patient privacy under the Health Insurance Portability and Accountability Act (HIPAA), restrictions on the teleprescribing of controlled substances under the purview of the U.S. Drug Enforcement Administration (DEA), and service location limits under the Centers for Medicare & Medicaid Services (CMS).

State Laws

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Medical licensure & corporate practice of medicine—To provide medical services, including telemedicine services, to a resident of a state, the treating physician is generally required to be licensed in that state. There is no comprehensive licensing scheme for telemedicine, so physicians must comply with licensure requirements in every state in which they seek to provide telemedicine services.

According to the American Telemedicine Association (ATA), 41 states have passed laws aimed at improving coverage and reimbursement of telehealth services since 2017. Thirty states have adopted the Federation of State Medical Boards’ Interstate Medical Licensure Compact, which allows for expedited licensure in the participating states.

Alternatively, six states, including Maryland and Virginia, have adopted laws for neighboring state reciprocity, and nine other states have created special telemedicine certificates that can be issued to out-of-state providers. These nine states are: Alabama, Louisiana, Minnesota, Nevada, New Mexico, Ohio, Oregon, Tennessee and Texas. Upon issuance, this certificate enables a provider to engage in telemedicine in accordance with the parameters governing such certificates.

An additional consideration is whether a state has a corporate practice of medicine prohibition, which generally prohibits corporations from practicing medicine or business entities from employing physicians to provide medical services. For example, in California, any business or management decisions that result in control over a physician’s decision making must be made by a licensed California physician and not by an unlicensed person or entity.

Telemedicine can be very expensive, and large corporations are generally in the best position to afford the resources required to provide telemedicine services. Even if there is no corporate practice of medicine prohibition in the state where the corporation is located, the state in which the telemedicine services are provided may have such a prohibition, which effectively precludes the corporation from operating in that state. If telemedicine services are provided by the corporation, it may be in violation of the law and subject to penalties—unless an exception to the law applies.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Legal UpdatesProfessional Topics Tagged with:COVID-19telehealthtelemedicine

Related Articles

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19

    April 24, 2020

    Humans may fear change as a general rule, but we’re adaptable when we need to be. In this era of COVID-19 and social distancing, medical practices and payers are adapting to an increased use of telemedicine, which enables providers to see their patients without being in a room with them. To cope, the Centers for…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences